Relapse of VAD Infections After Discontinuation of Anti-infective Therapies in Children.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

Heart failure is a major cause of mortality and morbidity in children. Heart transplantation can significantly improve the prognosis of patients with severe heart failure, but access is limited by a shortage of transplants. Long-term mechanical circulatory support is a major advance in the management of heart failure and can provide haemodynamic support while awaiting myocardial recovery or heart transplantation. The Berlin Heart (BH) EXCOR is the only long-term support system available for children. Despite technical and medical advances in circulatory support, infection is a common complication and a major cause of morbidity and mortality in patients on BH. There are few studies on the management of infection with mechanical support. Current ISHLT (International Society for Heart and Lung Transplantation) recommendations are based on expert opinion and observational studies. Some experts recommend anti-infective therapy until transplantation for specific support infections or for support-associated infections with persistent bacteraemia.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 day
Maximum Age: 18
Healthy Volunteers: f
View:

• patients under 18yo of age with Berlin Heart assisting device in Hospices Civils de Lyon, in France.

Locations
Other Locations
France
Hospices Civils de Lyon
RECRUITING
Lyon
Contact Information
Primary
Charlotte Leclercq, MD PhD
chaleclercq@gmail.com
+33787022785
Backup
Marc Lilot, MCU
marc.lilot@chu-lyon.fr
+33651806521
Time Frame
Start Date: 2023-07-04
Estimated Completion Date: 2025-11-01
Participants
Target number of participants: 47
Treatments
Pediatric patients with Berlin Heart EXCOR
Patient under 18 years old of age at the time of BH assistance in HCL Lyon France
Sponsors
Collaborators: Hospices Civils de Lyon
Leads: Claude Bernard University

This content was sourced from clinicaltrials.gov